First Examination Report (FER)
After filing Form 18 (Request for Examination), the application is assigned to a patent examiner who conducts a thorough examination and issues the First Examination Report (FER). The FER is the first official communication from the Patent Office detailing objections to the application.
Contents of FER
A typical FER contains:
- Prior Art Citations: Patents and publications cited against novelty and inventive step
- Section 3 Objections: If any claim falls under excluded subject matter
- Claim Objections: Clarity, support, scope issues
- Specification Deficiencies: Insufficient description, enablement issues
- Formal Objections: Form/fee deficiencies, document issues
- Unity of Invention: If claims cover multiple inventions
The applicant must respond to the FER within 6 months from the date of issuance. This period can be extended by a maximum of 3 months by filing Form 4 with the prescribed extension fee. No further extension is permitted.
Common Controller Objections and Responses
The examiner cites prior art documents (D1, D2, etc.) and alleges that the claimed invention is anticipated by one or more of these documents.
- Analyze each cited document carefully - does it really disclose ALL claim elements?
- Distinguish the claims by pointing out features absent in prior art
- Amend claims to include distinguishing features
- Argue that document does not provide "clear and unmistakable direction"
- Challenge the relevance of the citation (different technical field)
The examiner combines multiple prior art documents to argue that the claimed invention would have been obvious to a person skilled in the art.
- Challenge the combination - is there motivation to combine?
- Argue unexpected technical effect or synergistic result
- Present secondary evidence: commercial success, long-felt need, failure of others
- Argue that prior art teaches away from the invention
- Emphasize technical advance or economic significance
For pharmaceutical applications, the examiner alleges the claims are for a new form of a known substance without enhanced efficacy.
- Provide comparative data showing enhanced therapeutic efficacy
- Demonstrate improved bioavailability leading to better therapeutic outcome
- Show reduced toxicity with maintained efficacy
- Argue the compound is not a "known substance" under Section 3(d)
- Submit clinical or pre-clinical data supporting enhanced efficacy
For software-related inventions, the examiner alleges claims are directed to computer programs per se.
- Emphasize the technical problem solved and technical effect achieved
- Draft claims as method/system, not pure software
- Show hardware interaction and technical implementation
- Highlight improvement in computer functioning or technology
- Follow CRI (Computer Related Inventions) Guidelines
The specification does not sufficiently describe the invention to enable a person skilled in the art to perform it.
- Point out where enablement is provided in the specification
- Argue that POSITA would understand with reasonable experimentation
- Limit claims to enabled embodiments
- Submit additional experimental data as supplementary information
The scope of claims exceeds what is disclosed and supported in the specification.
- Identify support for each claim element in the specification
- Amend claims to match the described embodiments
- Add dependent claims for specific embodiments
- Narrow broad claim language to supported scope
Claim Amendments
Claim amendments are a critical tool during prosecution to overcome objections and secure patent grant. However, amendments are subject to important restrictions.
Principles Governing Amendments
- No New Matter: Cannot add subject matter not disclosed in original specification
- No Broadening: Cannot expand claim scope after grant (pre-grant broadening may be allowed)
- Unity: Amendments must not result in multiple inventions
- Fair Basis: Amended claims must be supported by the specification
Types of Permissible Amendments
- Adding limitations from specification to narrow claims
- Combining dependent claims into independent claims
- Correcting clerical errors
- Clarifying claim language without changing scope
- Deleting claims or narrowing claim scope
When filing amendments, provide: (1) Clean copy of amended specification/claims; (2) Marked-up copy showing all changes; (3) Explanation of amendments and their basis in the original specification; (4) Arguments addressing the Controller's objections.
Hearing Procedures
If objections cannot be resolved through written submissions, the applicant may request a hearing before the Controller. Hearings provide an opportunity for oral arguments and clarification.
When is a Hearing Required?
- Complex technical or legal issues requiring explanation
- Disagreement persists after written response to FER
- Opposition proceedings (post-grant opposition has hearing as of right)
- Applicant believes written response insufficient to convey position
Hearing Procedure
- Request: File request for hearing with Form 19
- Notice: Controller issues hearing notice with date, time, venue
- Preparation: Prepare detailed submissions, exhibits, arguments
- Representation: Applicant/agent/advocate can appear
- Presentation: Oral arguments presented to Controller
- Record: Written record of hearing maintained
- Decision: Controller issues written decision after hearing
Prepare written synopsis of arguments; bring prior art documents and specification copies; be concise and focus on key issues; address each objection systematically; be prepared for Controller's questions; request adjournment if new issues arise.
Grant of Patent
Once all objections are overcome and opposition proceedings (if any) are decided favorably, the Controller proceeds to grant the patent.
Grant Process
- Controller satisfied all requirements met
- No pending opposition or opposition decided favorably
- Patent granted with effect from filing date
- Patent published in Official Gazette/Patent Journal
- Certificate of Patent issued to patentee
- Patent term: 20 years from filing date
Post-Grant Requirements
- Renewal Fees: Annual fees payable from 3rd year onwards
- Working Statement: Form 27 to be filed annually
- Assignment Recording: Any transfer must be recorded
- Marking: Products should bear patent number
Timeline Management
1. Maintain docket/calendar with all deadlines
2. Set reminders well in advance of due dates
3. Track foreign counterparts for Form 3 updates
4. Plan examination request strategically (later gives more time)
5. Use early publication if quick grant needed